Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ESPB for Postoperative Pain in Thoracotomy
NCT06750627Phase 4Not yet recruiting
- Sponsor
- Udayana University
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Udayana University. Primary endpoints: Resting Pain Score at 48 hours and Coughing Pain Score at 48 hours. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06750627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06750627.